Bristol Myers Squibb to Take Part in the 7th Annual Truist Life Sciences Summit
NEW YORK–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in a fireside chat at the 7th Annual Virtual Truist Life Sciences Summit, which will be webcast on Wednesday, May 5, 2021. Adam Lenkowsky, Senior Vice President, General Manager of U.S. Oncology, Immunology and CV and Winselow Tucker, Senior Vice President, General Manager, U.S. Hematology will answer questions about the company at 8 a.m. ET.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20210428005109/en/
Bristol Myers Squibb
Media:
[email protected]
Investor Relations:
Tim Power
609-252-7509
[email protected]
Nina Goworek
908-673-9711
[email protected]
KEYWORDS: United States North America New York
INDUSTRY KEYWORDS: Biotechnology Health Pharmaceutical Clinical Trials Oncology
MEDIA:
| Logo |
 |